Recent Advances and Challenges in Uveal Melanoma Immunotherapy

Recent Advances and Challenges in Uveal Melanoma Immunotherapy

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Compared to cutaneous melanoma (CM), which mainly harbors <i>BRAF</i> or <i>NRAS</i> mutations, UM predominantly harbors <i>GNAQ</i> or <i>GNA11</i> mutations. Although pr...

Full description

Bibliographic Details
Main Authors: Yihang Fu, Wei Xiao, Yuxiang Mao
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
immune checkpoint inhibitors
HDAC inhibitors
oncolytic virus
tebentafusp
uveal melanoma
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/14/13/3094

Internet

https://www.mdpi.com/2072-6694/14/13/3094

Similar Items